Clinical Review: Critical Illness Polyneuropathy and Myopathy

Overview

Journal Crit Care

Specialty Critical Care

Date 2008 Dec 2

PMID 19040777

Citations 86

Authors

Greet Hermans

Bernard de Jonghe

Frans Bruyninckx

Greet Van den Berghe

Affiliations

Soon will be listed here.

Abstract

Critical illness polyneuropathy (CIP) and myopathy (CIM) are major complications of severe critical illness and its management. CIP/CIM prolongs weaning from mechanical ventilation and physical rehabilitation since both limb and respiratory muscles can be affected. Among many risk factors implicated, sepsis, systemic inflammatory response syndrome, and multiple organ failure appear to play a crucial role in CIP/CIM. This review focuses on epidemiology, diagnostic challenges, the current understanding of pathophysiology, risk factors, important clinical consequences, and potential interventions to reduce the incidence of CIP/CIM. CIP/CIM is associated with increased hospital and intensive care unit (ICU) stays and increased mortality rates. Recently, it was shown in a single centre that intensive insulin therapy significantly reduced the electrophysiological incidence of CIP/CIM and the need for prolonged mechanical ventilation in patients in a medical or surgical ICU for at least 1 week. The electrophysiological diagnosis was limited by the fact that muscle membrane inexcitability was not detected. These results have yet to be confirmed in a larger patient population. One of the main risks of this therapy is hypoglycemia. Also, conflicting evidence concerning the neuromuscular effects of corticosteroids exists. A systematic review of the available literature on the optimal approach for preventing CIP/CIM seems warranted.

Citing Articles

Ultrasonographic assessment of the muscle mass of the rectus femoris in mechanically ventilated patients at intensive care unit discharge is associated with deterioration of functional status at hospital discharge: a prospective cohort study.

Quadros T, Horn T, Moraes M, Selmo L, Ribas A, Blattner C Crit Care Sci. 2025; 37:e20250050.

PMID: 39936772 PMC: 11805460. DOI: 10.62675/2965-2774.20250050.

Clinical characteristics and predictive biomarkers of intensive care unit-acquired weakness in patients with cardiogenic shock requiring mechanical circulatory support.

Higuchi T, Ide T, Fujino T, Tohyama T, Nagatomi Y, Nezu T Sci Rep. 2025; 15(1):3535.

PMID: 39875476 PMC: 11775089. DOI: 10.1038/s41598-025-87381-1.

Ultramicronized Palmitoylethanolamide and Luteolin: Drug Candidates in Post-COVID-19 Critical Illness Neuropathy and Positioning-Related Peripheral Nerve Injury of the Upper Extremity.

Roncati L, Marra C, Gravina D, Di Massa G, Della Rosa N, Adani R J Hand Microsurg. 2024; 16(2):100028.

PMID: 38855524 PMC: 11144630. DOI: 10.1055/s-0043-1764161.

Deep Machine Learning Might Aid in Combating Intensive Care Unit-Acquired Weakness.

Panda C, Karim H Cureus. 2024; 16(4):e58963.

PMID: 38800279 PMC: 11126887. DOI: 10.7759/cureus.58963.

Outcome, predictors and longitudinal trajectories of subjects with critical illness polyneuropathy and myopathy (CINAMOPS): study protocol of an observational cohort study in a clinical and post-clinical setting.

Bergmann J, Egger M, Muller F, Jahn K BMJ Open. 2024; 14(4):e083553.

PMID: 38670603 PMC: 11057271. DOI: 10.1136/bmjopen-2023-083553.

References

Bolton C, Young G, Zochodne D . The neurological complications of sepsis. Ann Neurol. 1993; 33(1):94-100. DOI: 10.1002/ana.410330115. View

Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters P . Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005; 64(8):1348-53. DOI: 10.1212/01.WNL.0000158442.08857.FC. View

Hund E . Myopathy in critically ill patients. Crit Care Med. 1999; 27(11):2544-7. DOI: 10.1097/00003246-199911000-00036. View

Kleyweg R, van der Meche F, Schmitz P . Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991; 14(11):1103-9. DOI: 10.1002/mus.880141111. View

De Letter M, van Doorn P, Savelkoul H, Laman J, Schmitz P, Op de Coul A . Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol. 2000; 106(1-2):206-13. DOI: 10.1016/s0165-5728(99)00252-0. View

Barohn R, Jackson C, Rogers S, Ridings L, McVey A . Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve. 1994; 17(6):647-54. DOI: 10.1002/mus.880170613. View

Boles J, Bion J, Connors A, Herridge M, Marsh B, Melot C . Weaning from mechanical ventilation. Eur Respir J. 2007; 29(5):1033-56. DOI: 10.1183/09031936.00010206. View

Cankayali I, Dogan Y, Solak I, Demirag K, Eris O, Demirgoren S . Neuromuscular deterioration in the early stage of sepsis in rats. Crit Care. 2007; 11(1):R1. PMC: 2151871. DOI: 10.1186/cc5139. View

Kerbaul F, Brousse M, Collart F, Pellissier J, Planche D, Fernandez C . Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromes. Crit Care. 2004; 8(6):R358-66. PMC: 1065049. DOI: 10.1186/cc2925. View

10.

Tiao G, Hobler S, Wang J, Meyer T, Luchette F, Fischer J . Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest. 1997; 99(2):163-8. PMC: 507782. DOI: 10.1172/JCI119143. View

11.

Lacomis D, Petrella J, Giuliani M . Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve. 1998; 21(5):610-7. DOI: 10.1002/(sici)1097-4598(199805)21:5<610::aid-mus7>3.0.co;2-b. View

12.

Stibler H, Edstrom L, Ahlbeck K, Remahl S, Ansved T . Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med. 2003; 29(9):1515-27. DOI: 10.1007/s00134-003-1894-9. View

13.

Levine S, Nguyen T, Taylor N, Friscia M, Budak M, Rothenberg P . Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008; 358(13):1327-35. DOI: 10.1056/NEJMoa070447. View

14.

Rossignol B, Gueret G, Pennec J, Morel J, Giroux-Metges M, Talarmin H . Effects of chronic sepsis on the voltage-gated sodium channel in isolated rat muscle fibers. Crit Care Med. 2007; 35(2):351-7. DOI: 10.1097/01.CCM.0000254335.88023.0E. View

15.

Hermans G, de Jonghe B, Bruyninckx F, Van den Berghe G . Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev. 2009; (1):CD006832. DOI: 10.1002/14651858.CD006832.pub2. View

16.

Tennila A, Salmi T, Pettila V, Roine R, Varpula T, Takkunen O . Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med. 2000; 26(9):1360-3. DOI: 10.1007/s001340000586. View

17.

Teener J, Rich M . Dysregulation of sodium channel gating in critical illness myopathy. J Muscle Res Cell Motil. 2006; 27(5-7):291-6. DOI: 10.1007/s10974-006-9074-5. View

18.

Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters P, Skogstrand K . Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005; 115(8):2277-86. PMC: 1180545. DOI: 10.1172/JCI25385. View

19.

Yu Y, Ryan C, Fei Z, Lu X, Castillo L, Schultz J . Plasma L-5-oxoproline kinetics and whole blood glutathione synthesis rates in severely burned adult humans. Am J Physiol Endocrinol Metab. 2002; 282(2):E247-58. DOI: 10.1152/ajpendo.00206.2001. View

20.

de Jonghe B, Bastuji-Garin S, Durand M, Malissin I, Rodrigues P, Cerf C . Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med. 2007; 35(9):2007-15. DOI: 10.1097/01.ccm.0000281450.01881.d8. View